Binding affinity independent contribution of peptide length to the stability of peptide-HLA-DR complexes in live antigen presenting cells

被引:15
作者
Siklodi, B
Vogt, AB
Kropshofer, H
Falcioni, F
Molina, M
Bolin, DR
Campbell, R
Hämmerling, GJ
Nagy, ZA
机构
[1] Hoffmann La Roche Inc, Dept Immunol, Nutley, NJ 07110 USA
[2] Hoffmann La Roche Inc, Dept Inflammat & Autoimmune Dis, Nutley, NJ 07110 USA
[3] German Canc Res Ctr, Dept Mol Immunol, D-69120 Heidelberg, Germany
关键词
D O I
10.1016/S0198-8859(98)00038-X
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The effect of peptide length on the stability of peptide-HLR-DR1 (DR1) complexes was analyzed using two peptide series of increasing length, each containing a 7 mer core with five DR1-binding anchors, extended stepwise with Ala residues at the N- and C-terminus, respectively. The Ala extensions, although did not affect binding affinity, significantly increased the half lives of peptide-DR1 complexes (from 1.5 h up to 10 h) in live antigen presenting cells (APC). Flanking residues from position -2 to 0 and 8 to 11 were involved in the affinity-independent increase of complex stability. The shortest (8 mer and 9 mer) peptides, with in vivo half lives of <2.5 h, were unable to form stable complexes with DR1 in presence of HLA-DM (DM) molecules, and were poor competitors of antigen presentation. Longer peptides were resistant to DM-mediated unloading, and were efficient competitors of antigen presentation. Thus, DM appears to limit short peptides in establishing biologically relevant DR occupancy, despite their high binding affinity. In APC, stable complexes can form only with high affinity peptides of >9 residues, and the longevity of complexes seems to depend on full of occupation of the binding site. Human Immunology 59, 463-471 (1998). (C) American Society for Histocompatibility and Immunogenetics, 1998. Published by Elsevier Science Inc.
引用
收藏
页码:463 / 471
页数:9
相关论文
共 33 条
[11]   HIGH-AFFINITY BINDING OF SHORT PEPTIDES TO MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-II MOLECULES BY ANCHOR COMBINATIONS [J].
HAMMER, J ;
BELUNIS, C ;
BOLIN, D ;
PAPADOPOULOS, J ;
WALSKY, R ;
HIGELIN, J ;
DANHO, W ;
SINIGAGLIA, F ;
NAGY, ZA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (10) :4456-4460
[12]   IDENTIFICATION OF A MOTIF FOR HLA-DR1 BINDING PEPTIDES USING M13 DISPLAY LIBRARIES [J].
HAMMER, J ;
TAKACS, B ;
SINIGAGLIA, F .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (04) :1007-1013
[13]   PROMISCUOUS AND ALLELE-SPECIFIC ANCHORS IN HLA-DR-BINDING PEPTIDES [J].
HAMMER, J ;
VALSASNINI, P ;
TOLBA, K ;
BOLIN, D ;
HIGELIN, J ;
TAKACS, B ;
SINIGAGLIA, F .
CELL, 1993, 74 (01) :197-203
[14]   PRECISE PREDICTION OF MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-II PEPTIDE INTERACTION BASED ON PEPTIDE SIDE-CHAIN SCANNING [J].
HAMMER, J ;
BONO, E ;
GALLAZZI, F ;
BELUNIS, C ;
NAGY, Z ;
SINIGAGLIA, F .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (06) :2353-2358
[15]   TURNOVER OF IA PEPTIDE COMPLEXES IS FACILITATED IN VIABLE ANTIGEN-PRESENTING CELLS - BIOSYNTHETIC TURNOVER OF IA VS PEPTIDE EXCHANGE [J].
HARDING, CV ;
ROOF, RW ;
UNANUE, ER .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (11) :4230-4234
[16]   QUANTITATION OF ANTIGEN-PRESENTING CELL MHC CLASS-II PEPTIDE COMPLEXES NECESSARY FOR T-CELL STIMULATION [J].
HARDING, CV ;
UNANUE, ER .
NATURE, 1990, 346 (6284) :574-576
[17]   HLA-DR4-IE chimeric class II transgenic, murine class II-deficient mice are susceptible to experimental allergic encephalomyelitis [J].
Ito, K ;
Bian, HJ ;
Molina, M ;
Han, JH ;
Magram, J ;
Saar, E ;
Belunis, C ;
Bolin, DR ;
Arceo, R ;
Campbell, R ;
Falcioni, F ;
Vidovic, D ;
Hammer, J ;
Nagy, ZA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (06) :2635-2644
[18]   Invariant chain and DM edit self-peptide presentation by major histocompatibility complex (MHC) class II molecules [J].
Katz, JF ;
Stebbins, C ;
Appella, E ;
Sant, AJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (05) :1747-1753
[19]   Editing of the HLA-DR-peptide repertoire by HLA-DM [J].
Kropshofer, H ;
Vogt, AB ;
Moldenhauer, G ;
Hammer, J ;
Blum, JS ;
Hammerling, GJ .
EMBO JOURNAL, 1996, 15 (22) :6144-6154
[20]   HLA-DM acts as a molecular chaperone and rescues empty HLA-DR molecules at lysosomal pH [J].
Kropshofer, H ;
Arndt, SO ;
Moldenhauer, G ;
Hammerling, GJ ;
Vogt, AB .
IMMUNITY, 1997, 6 (03) :293-302